ロード中...
Novel molecular targets in hepatocellular carcinoma
Globally, hepatocellular carcinoma (HCC) is a leading cause of cancer and cancer-related deaths. The therapeutic efficacy of locoregional and systemic treatment in patients with advanced HCC remains low, which results in a poor prognosis. The development of sorafenib for the treatment of HCC has res...
保存先:
| 出版年: | World J Clin Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7443834/ https://ncbi.nlm.nih.gov/pubmed/32879846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i8.589 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|